Moreover, MYC upregulation is an early event in human prostate cancer (Gurel et al., 2008), and MYC overexpression is sufficient to transform luminal epithelial cells into pre-malignant derivatives in the mouse prostatic gland (Kim et al., 2009; Iwata et al., 2010). This evidence concerns the gene MYC and prostate cancer.